Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.

Autor: Katodritou, Eirini, Terpos, Evangelos, Kelaidi, Charikleia, Kotsopoulou, Maria, Delimpasi, Sossana, Kyrtsonis, Marie-Christine, Symeonidis, Argiris, Giannakoulas, Nikos, Stefanoudaki, Aikaterini, Christoulas, Dimitrios, Chatziaggelidou, Christina, Gastari, Vassiliki, Spyridis, Nikos, Verrou, Evgenia, Konstantinidou, Pavlina, Zervas, Kostas, Dimopoulos, Meletios A.
Zdroj: American Journal of Hematology; Feb2014, Vol. 89 Issue 2, p145-150, 6p
Databáze: Complementary Index
Externí odkaz: